Skip to content
SLETOR
OpenGrant

Small molecule high throughput screen using AstraZeneca facilities (Grant)[E8]

United KingdomUK Research and Innovation, Medical Research Council[E1]

Closes[E3]
Funder's deadline: 28 Jan 2027, 16:00 UK time (UTC). UTC: 28 Jan 2027, 16:00 UTC.
Total funding[E9]
GBP 1,000,000Up to GBP 270,000 for one applicant.
Bid language
Your language
Sign in to track this bidAdd deadline to calendar
Funder's page (opens in a new tab)

In plain English

What it funds

Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year that are open to all targets. Location: National. Award: £1 to £270,000. Total fund: £1,000,000.

Who can apply
  • public sector, non-profit, private sector.
  • Open to: Small and medium firms
  • Open to: Nonprofits
  • Open to: Public bodies
Guidance and application

The funder's guidance, rules and application form are on its own page. Read them before you apply.

Risks and unknowns

  • RiskThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
  • UnknownWe read the funder's listing, not the full guidance or application forms.
Opens[E6]
10 Sept 2026
Source
UK Find a grant (government grants, all UK nations) (opens in a new tab)
Last checked
7 hours ago

Who can apply

  • EligibilityWho can apply: public sector, non-profit, private sector.[E4]
  • Open toSmall and medium firms, Nonprofits, Public bodies. Tagged by SLETOR from the listing's own words.

Funder

What else this funder offers

UK Research and Innovation, Medical Research Council

The call gives no contact route for the funder beyond the original page.

How to ask a question

Ask questions through the funder's own page or enquiry route. Check the guidance first. Open the buyer's route

We show only the organisation's own contact route as published: its website, portal, shared mailboxes and main lines. Never a named person.

Evidence10 facts from the notice · Show

Every fact on this page comes from the funder's listing. Each entry shows the record and the field it was read from.

  1. E1

    The funder is UK Research and Innovation, Medical Research Council.

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantFunder, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  2. E2

    The grant is listed on the UK government's Find a grant service.

    “GB”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantLocation, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  3. E3

    Applications close on 28 Jan 2027, 16:00 UK time (UTC).

    “2027-01-28T16:00”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantApplicationCloseDate, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  4. E4

    Who can apply: public sector, non-profit, private sector.

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantApplicantType, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  5. E5

    This is a UK government grant. Applicants apply to the funder.

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), the whole record, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  6. E6

    Applications open on 10 Sept 2026, 09:00 UK time (UTC+1).

    “2026-09-10T09:00”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantApplicationOpenDate, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  7. E7

    When we read it, the call was open, going by the open and close dates on Find a grant.

    “2027-01-28T16:00”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantApplicationCloseDate, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  8. E8

    The notice is titled "Small molecule high throughput screen using AstraZeneca facilities (Grant)".

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantName, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  9. E9

    The stated value is GBP 1,000,000 (the total fund, shared between applicants).

    “1000000 GBP”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantTotalAwardAmount, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

  10. E10

    The most one applicant can get is GBP 270,000.

    “270000 GBP”

    From Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM), field /grantMaximumAward, read 29 Oct 2026, 09:13 UTC · source (opens in a new tab)

Contains public sector information from Find a grant, licensed under the Open Government Licence v3.0. Data licence: Open Government Licence v3.0 (opens in a new tab). Personal contact details in notices are not stored or shown.

Updates

  1. First seen · 29 Oct 2026, 09:13 UTC

    The funder published the call with a future closing date.

    Source record: Small molecule high throughput screen using AstraZeneca facilities (Grant) (ID 4x5NSM9HEsfFy6D1DC4UkM)